Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Completes Budapest R&D Site | Contract Pharma
Breaking News

AMRI Completes Budapest R&D Site

AMRI has finished the construction of a new state-of-the-art chemistry R&D facility in Budapest, Hungary.

AMRI has finished the construction of a new state-of-the-art chemistry R&D facility in Budapest, Hungary. The successful completion and move into 32,300 sq. ft. of laboratory and administrative space is part of the company’s plan, initiated in 2008, to transform its European hub into a higher value discovery services business through consolidation of multiple locations, equipment and operating costs.

The new site provides capacity for the anticipated expansion of synthetic chemistry services, currently projected to double over the next five years.The facility also includes a scale-up laboratory for non-GMP synthesis for batch sizes as large as 25 liters. AMRI also contends it will offer “significant improvements in operational efficiencies and enhanced technology transfer.”

“The successful completion of this expansion increases the ability of AMRI to execute on its strategy to accelerate growth and expand its presence in the European marketplace,” said chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “Critical to the decision to undertake this project was the company’s drive to cultivate a customer base relatively untapped. We believe this latest investment, along with our parallel investments in the US, India and Singapore, will further strengthen AMRI’s presence as a premier provider of a broad range of scientific services, capabilities and geographic choices around the globe.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters